Contributors

Meet some of the people featured in the July 2012 issue of The Scientist.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Keith D. Wilkinson (far left) began studying the ubiquitin pathway in 1979 because it was “brand new.” He was recruited to Nobel Prize–winner Irwin Rose’s lab at the Fox Chase Cancer Center just a few short years after ubiquitin was first discovered. Today, Wilkinson is still figuring out the mysteries of a protein that is found in all eukaryotic cells and is fundamental to the cell cycle. He is currently identifying a host of enzymes that regulate ubiquitin-dependent processes, with the expectation that the enzymes will be good drug targets in disease. Wilkinson first met his coauthor David Fushman at a biannual ubiquitin meeting, where “everybody who is anybody in this field got their start.” Chains of ubiquitin are only distinguished by their pattern of connections, and Fushman wants to understand how the connections affect the signaling process. In their feature article, "On the Chain Gang," you can read about ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies